This page shows the latest Kevzara news and features for those working in and with pharma, biotech and healthcare.
Actemra and Kevzara also improved recovery times among critically ill COVID-19 patients. ... Both Actemra and Kevzara are IL-6 receptor agonists and are most commonly used to treat anti-inflammatory conditions, including arthritis.
This includes Roche’s Actemra (tocilizumab) and Sanofi and Regeneron’s Kevzara (sarilumab), with both drugs entering clinical trials evaluating their efficacy in severely ill COVID-19 patients. ... Kevzara was also unable to prevent death or help
This includes Sanofi’s Kevzara (sarilumab) and Roche’s Actemra (tocilizumab), although both of these drugs failed their respective studies in COVID-19. ... Despite the disappointing results, Roche is continuing its investigation of Actemra in severe
A number of other anti-inflammatory drugs have also failed to hit the mark in COVID-19, including Sanofi/Regeneron’s rheumatoid arthritis drug Kevzara (sarilumab) and Roche’s Actemra (tocilizumab).
Sanofi/Regeneron’s IL-6 inhibitor Kevzara (sarilumab) was also unable to prevent death or help patients come off ventilation among mechanically ventilated patients. ... remdesivir. The Swiss pharma company is also evaluating Kevzara in
The progress of REGN-COV2 is welcome news for Regeneron, after it had to abandon its Sanofi-partnered study of Kevzara (sarilumab) following disappointing results in a phase 3 trial. ... With Kevzara falling by the wayside, Regeneron is now pinning its
More from news
Approximately 6 fully matching, plus 24 partially matching documents found.
Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... Encouraged by this initial data, Sanofi and
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...